This page shows the latest annual results news and features for those working in and with pharma, biotech and healthcare.
CML). The detailed results, presented at the annual American Society of Hematology (ASH) meeting, come from the phase 3 ASCEMBL study. ... There is a clear need in later lines of therapy and, based on these results, we believe asciminib may become an
Results presented at annual American Society of Haematology (ASH) meeting. bluebird bio has revealed some long-term data for its gene therapy betibeglogene autotemcel, which is marketed as Zynteglo in the ... bluebird bio announced the new long-term data
It hopes to “define next steps for the clinical programme to bring palovarotene to patients as quickly as possible”, according to its annual results statement. ... Rival candidates for FOP are however coming through the pipeline, including
Drug improved survival by almost ten months. Bristol-Myers Squibb has scored significant overall survival results in a phase 3 trial of its oral maintenance therapy CC-486 in acute myeloid ... During a presentation of the results at the annual ASH 2019
It will start shipping the product in the US later this week with an annual price of $292, 000, a little higher than the list price for Orkambi. ... Vertex’ chief executive Jeff Leiden said during the company’s annual results meeting that it
Both are "reasons for concern", given the importance of "reliable and innovation-friendly conditions in our markets", he told a press briefing on the company's annual results at its headquarters
More from news
Approximately 0 fully matching, plus 40 partially matching documents found.
to nurses, what nurses needed. Using these insights, Jango developed a bespoke annual meeting event that was strongly educational and promoted patient care, and was also personally and professionally rewarding. ... This annual educational meeting has now
The Edelman Trust Barometer is all about earning trust. We often use our annual survey results to inform client programmes. ... In 2018, results found the most trusted ‘voices. of authority’ to be technical and academic experts.
Ahmad, speaking at a satellite session at the company’s annual results conference earlier this year, revealed that 10% of hospital Trusts in England have contracts with Novartis which is leading
We see many marketers going through the familiar drill of filling in brand templates and presenting the results at the ‘annual review’- but in some cases it’s simply viewed as
The Practical Guide was launched as part of a Takeda sponsored symposium at the British Sarcoma Group’s annual conference. ... launched. Takeda’s KAM team distributed the guide to HCPs throughout the UK and at the British Oncology Pharmacy
More from intelligence
Approximately 0 fully matching, plus 6 partially matching documents found.
Everyone is under pressure to deliver results fast, so how can you speed up the positive effects of your e-detailing and multichannel communication?
More from PMHub
Approximately 1 fully matching, plus 0 partially matching documents found.
We’re IGNIFI. An independent creative agency, we help spark and sustain successful brands for some of the biggest names in...